Cyprotex Share Discussion Threads

[tolrem2] 21/7/2016 22:47

Where is Buywell when we need his words of wisdom?

[husbod] 21/7/2016 10:56

Some profit taking now but hardly surprising.

The interest rate on the loan notes is 5% rrb - is that more or less in line with what the bank would charge a company like CRX and if it is then there is no real reason to redeem the notes at some sort of premium - which would be necessary for the holders to forego that sort of return.

The only reason they are looking at the loan notes is the technical point about insolvent trading rather than the yield on the notes.

[rrb] 21/7/2016 10:14

agreed on dilution. Then the best thing for us all is the share price stays depressed until late 2018. I would expect interim results to show strong revenue and profitability growth but the non-cash hit due to share price.

[husbod] 21/7/2016 10:06

And more volume, albeit still modest, to what LTHs are accustomed.

These shares are very tightly held so even modest volume can shift the price quite a lot either way.

[battlebus2] 21/7/2016 09:31

Still moving higher.

[husbod] 21/7/2016 09:18

The problem with that rrb is it would certainly be a dilution for non-loan note holders and as there is one very major holder it will be highly dilutative (is there such a word) for all holders. Maybe they could do a 25% or 50% debt for equity swap shortly with the balance on the redemption date.

[rrb] 21/7/2016 08:00

If I were the CLN holders and the company, I would try to come to some sort of agreement to swap the debt for equity, which will allow all stakeholders to benefit from the momentum.

[husbod] 20/7/2016 19:08

The thing I like about these announcements is that the material increase in the revenue must mean the science/technology is working which in turn means we have a world leader here. If we can keep going like this the sky's the limit although they still have a to resolve the loan note issue. However if the revenue keeps growing like this then maybe servicing the interest will not be a problem Good stuff.

[rrb] 20/7/2016 16:55

Could the unexpected timing suggest someone is eyeing them up? Just wondering. Whatever it is, fantastic news. How can this thing only trade at a mcap of £31m?!

[battlebus2] 20/7/2016 15:33

Yes fabulous update and up we go!!!!

[p1nkfish] 20/7/2016 14:03

Forecasts out the window for the right reasons. Well done all.

[husbod] 20/7/2016 13:51

Excellent newsBeating expectations is the new normal!Even more amazing given that we all thought the loan note situation would limit the share price to about 60p

[bahiflyer] 20/7/2016 13:38

Bummer, ive been trying all week for more with a £1.20 limit order. Not much chance of getting that now.
hopefully it'll drift back a bit before the interims which will undoubtably be stunning with an update on the review which should solve the loan note issue.

[deadly] 20/7/2016 12:53

Wow, that TU wasn't expected was it?
Excellent news!

"The financial performance of the Company for the first half of the year is significantly ahead of the Boards expectations, comparative period performance and internal budgets.

The Board expects to announce the Interim Results of the Company on 2 August 2016. "

[bahiflyer] 13/7/2016 17:16

Interims should be interesting when they come out in a few weeks.
Whatever profit has been made this time (and I anticipate around £4M), will not be reduced to a loss but will actually benefit from a small gain due to the average monthly price for June being around 10p below the starting point of 122p for the period.

They may well throw in some amortisation/depreciation charges but the cash flow and cash in hand at period end will reveal just how profitable CRX currently is.

Reading their own blog of what they're doing as well as the other updates and new positions in U.S as well as here, tells me they've been extremely busy.
Ive been adding also.

[chadders] 11/7/2016 21:36

Husbod, I share your enthusiasm for CRX. Seems to have excellent management that's investing in ground-breaking technology. Added a few more last week. Definitely a keeper for me.

Into VENN as well.

[husbod] 11/7/2016 16:54

Hmmm. I do enjoy talking to myself but cannot help mentioning that 11k buy at the full ask. Will be another RNS tomorrow.

[husbod] 07/7/2016 18:44

Another new product launch. They're certainly not standing still whilst they carry out their organisational review. All very exciting/encouragingI miss old buywell who always commented on developments. Everyone seems to be sleeping in the background.

[husbod] 05/7/2016 10:00

Not sure that RNS is correct - surely the 10k was a buy not a sale. I await the correction.

Wonder how the deliberations are going. Should be an announcement fairly soon I would have thought.

[husbod] 04/7/2016 14:14

Nice 10k buy at the full ask - Mr Sneller upping his stake further?

[battlebus2] 23/6/2016 08:08

Launch of new Edocrine disruption service.

[bahiflyer] 23/6/2016 07:59

Another great addition to CRX portfolio of offerings.
Looking forward to the AGM statement later

[husbod] 20/6/2016 17:05

Richard Sneller seems to like us.

I see he is the Emerging Markets manager with Baillie Gifford but spent a year researching small uk companies.

Obviously a man of some perspicacity.

Keep on buying (Richard) (sung to the tune of the Spencer Davies number. Youngsters here will have no idea what I'm talking about!

[p1nkfish] 16/6/2016 07:45

The suite of capabilities is getting wider, deeper and stronger all the time. Good release again today.